Abstract
A 22-year-old man was diagnosed with active mitral endocarditis 14 months after mitral valve repair. The responsible organism was methicillin-resistant Staphylococcus epidermidis. Transthoracic echocardiography showed an 8-mm patch of vegetation adhering to the anterior part of the artifcial ring. Although antibiotics (piperacillin, minocycline, imipenem/cilastatin, and ampicillin) were administered, the vegetation grew to 30 mm. Reoperation was performed 35 days after the diagnosis. Before surgery, there was mild mitral regurgitation without congestive heart failure. Re-repair was performed by removing the vegetation and the artificial ring, and mattress sutures repaired the circumferential sulcus formed by the artificial ring. Teicoplanin and minocycline were administered for 6 weeks. At 20 months, infective endocarditis was absent. Residual mitral regurgitation has been consistently mild. Although active mitral endocarditis after mitral valve repair is rare, prompt reoperation should be considered if the responsible organism is drug-resistant and infection spreads to the artificial ring.
Similar content being viewed by others
References
Gillinov AM, Faber CN, Sabik JF, Pettersson G, Griffin BP, Gordon SM, et al. Endocarditis after mitral valve repair. Ann Thorac Surg 2002;73:1813–1816.
Alvarez JM, Deal CW, Loveridge K, Brennan P, Eisenberg R, Ward M, et al. Repairing the degenerative mitral valve: ten- to fifteen-year follow-up. J Thorac Cardiovasc Surg 1996;112: 238–247.
Gillinov AM, Cosgrove DM, Blackstone EH, Diaz R, Arnold JH, Lytle BW, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116: 734–743.
Braunberger E, Deloche A, Berrebi A, Abdallah F, Celestin JA, Meimoun P, et al. A very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation 2001;104(suppl 1):8–11.
Chauvaud S, Fuzellier JF, Berrebi A, Deloche A, Fabiani JN, Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001;104(suppl 1):12–15.
David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileafl et prolapse. J Thorac Cardiovasc Surg 2005;130:1242–1249.
Matthew AW. Zone diameter and MIC interpretive standards for Staphylococcus spp. In: Clinical and laboratory standards institute editor: performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. San Diego, CA: Pacific Beach Biosciences; 2009. p. 52–60.
Miyatake K, Akashi M, Ishizuka N, Eishi K, Kawazoe K, Nakazawa M, et al. The Japanese Circulation Society: guidelines for the prevention and treatment of infective endocarditis. <http://www.j-circ.or.jp/guideline/index.htm> [accessed 8 March 2009].
Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA, et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 2007;83:564–570.
Carpentier AF, Lessana A, Relland JY, Belli E, Mihaileanu S, Berrebi AJ, et al. The “physio-ring“: an advanced concept in mitral valve annuloplasty. Ann Thorac Surg 1995;60: 1177–1185.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miura, T., Eishi, K., Hashizume, K. et al. Active infective endocarditis after mitral valve repair. Gen Thorac Cardiovasc Surg 58, 49–52 (2010). https://doi.org/10.1007/s11748-009-0479-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-009-0479-0